Esperanza Martín‐Sánchez

705 total citations
21 papers, 224 citations indexed

About

Esperanza Martín‐Sánchez is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Esperanza Martín‐Sánchez has authored 21 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Esperanza Martín‐Sánchez's work include Epigenetics and DNA Methylation (4 papers), Cancer-related gene regulation (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Esperanza Martín‐Sánchez is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer-related gene regulation (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Esperanza Martín‐Sánchez collaborates with scholars based in Spain, United States and Czechia. Esperanza Martín‐Sánchez's co-authors include David Guerrero‐Setas, Alicia Córdoba, Idoia Blanco‐Luquin, Margarita Sánchez‐Beato, Miguel Á. Piris, Socorro Marıá Rodríguez-Pinilla, Raquel Pajares, David Escors, Lydia Sánchez-Verde and Pablo L. Ortiz‐Romero and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Esperanza Martín‐Sánchez

17 papers receiving 220 citations

Peers

Countries citing papers authored by Esperanza Martín‐Sánchez

Since Specialization

Citations

This map shows the geographic impact of Esperanza Martín‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esperanza Martín‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esperanza Martín‐Sánchez more than expected).

Fields of papers citing papers by Esperanza Martín‐Sánchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esperanza Martín‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esperanza Martín‐Sánchez. The network helps show where Esperanza Martín‐Sánchez may publish in the future.

Co-authorship network of co-authors of Esperanza Martín‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Esperanza Martín‐Sánchez. A scholar is included among the top collaborators of Esperanza Martín‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esperanza Martín‐Sánchez. Esperanza Martín‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia 2024 ·Blood Advances ·Esperanza Martín‐Sánchez, Laura Blanco, Peter Kim, Kamlesh Bisht, Hongfang Wang, Helgi van de Velde, Tomáš Jelı́nek, (unknown), Felipe Prósper, Jesús F. San Miguel, Ana Alfonso Piérola, Juan Bergua, Rebeca Rodríguez‐Veiga, Susana Vives, David Martínez‐Cuadrón, Pau Montesinos, Bruno Paiva, Aintzane Zabaleta	5
2	A CD38 / CD3xCD28 trispecific T‐cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti‐ CD38 monoclonal antibodies 2024 ·British Journal of Haematology ·Aintzane Zabaleta, Laura Blanco, Peter Kim, Kamlesh Bisht, Hongfang Wang, Helgi van de Velde, Marta Lasa, (unknown), Paula Rodríguez‐Otero, Jesús F. San Miguel, Bruno Paiva, Esperanza Martín‐Sánchez	5
3	Deep Characterization of Immune Dysfunction in Patients with Multiple Myeloma (MM) and Identification of Cellular Biomarkers for Tailored Vaccination Strategies 2023 ·Blood ·Esperanza Martín‐Sánchez, (unknown), (unknown), (unknown), Aintzane Zabaleta, Catarina Maia, Laura Blanco, (unknown), Carlos Grande, (unknown), (unknown), (unknown), Ernesto Pérez Persona, (unknown), (unknown), Carlos Panizo, Felipe Prósper, Jesús F. San Miguel, Paula Rodríguez‐Otero, Bruno Paiva	0
4	A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent for the Treatment of Older Patients with Acute Myeloid Leukemia (AML) 2023 ·Blood ·Aintzane Zabaleta, Esperanza Martín‐Sánchez, (unknown), Peter Kim, Kamlesh Bisht, Hongfang Wang, (unknown), Tomáš Jelı́nek, (unknown), Felipe Prósper, Jesús F. San Miguel, David Martínez‐Cuadrón, Pau Montesinos, Bruno Paiva	1
5	A CD38/CD28xCD3 Trispecific T-Cell Engager (TCE) As a Potentially Active Agent in Multiple Myeloma Patients Relapsed and/or Refractory (RRMM) to Anti-CD38 Monoclonal Antibodies (mAbs) 2023 ·Blood ·Aintzane Zabaleta, Laura Blanco, Peter Kim, Kamlesh Bisht, Hongfang Wang, (unknown), Marta Lasa, (unknown), Paula Rodríguez‐Otero, Jesús F. San Miguel, Bruno Paiva, Esperanza Martín‐Sánchez	4
6	Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix 2021 ·Cancers ·(unknown), Joaquín Fernández‐Irigoyen, Enrique Santamaría, Imanol Arozarena, David Guerrero‐Setas, (unknown), Rosa Guarch, August Vidal, (unknown), Xavier Matías‐Guiu, Karina Ausín, Carmen Gil, Rubén Hernández-Alcoceba, Esperanza Martín‐Sánchez	4
7	A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis 2021 ·Biomedicines ·(unknown), David Guerrero‐Setas, (unknown), (unknown), (unknown), Susana de la Cruz, Esperanza Martín‐Sánchez	5
8	ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Alicia Córdoba, (unknown), (unknown), (unknown), P. Armendáriz, (unknown), Esperanza Martín‐Sánchez, David Guerrero‐Setas	35
9	Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix 2020 ·International Journal of Molecular Sciences ·(unknown), Joaquín Fernández‐Irigoyen, Enrique Santamaría, (unknown), Rosa Guarch, David Guerrero‐Setas, August Vidal, (unknown), Xavier Matías‐Guiu, Karina Ausín, (unknown), Esperanza Martín‐Sánchez	14
10	PO-388 Epigenetic silencing of ZNF177 by MIR-877–3 p could be involved in cervical cancer progression 2018 ·ESMO Open ·Esperanza Martín‐Sánchez, Rosa Guarch, Idoia Blanco‐Luquin, (unknown), (unknown), (unknown), August Vidal, (unknown), (unknown), David Guerrero‐Setas	0
11	CDH22 hypermethylation is an independent prognostic biomarker in breast cancer 2017 ·Clinical Epigenetics ·Esperanza Martín‐Sánchez, (unknown), (unknown), (unknown), Alicia Córdoba, (unknown), Idoia Blanco‐Luquin, Susana de la Cruz, (unknown), David Guerrero‐Setas	11
12	CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer 2017 ·Oncotarget ·Esperanza Martín‐Sánchez, (unknown), (unknown), (unknown), Idoia Blanco‐Luquin, Alicia Córdoba, (unknown), (unknown), David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas	24
13	Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA 2016 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Esperanza Martín‐Sánchez, (unknown), (unknown), Alicia Córdoba, (unknown), (unknown), (unknown), (unknown), (unknown), Idoia Blanco‐Luquin, David Escors, (unknown), David Guerrero‐Setas	13
14	NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma 2014 ·Modern Pathology ·Lina Odqvist, Santiago Montes‐Moreno, (unknown), Ken H. Young, Esperanza Martín‐Sánchez, Laura Cereceda, Lydia Sánchez-Verde, Raquel Pajares, Manuela Mollejo, Manuel Fresno, Francisco Mazorra, C Ruiz-Marcellán, Margarita Sánchez‐Beato, Miguel Á. Piris	24
15	NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells 2013 ·Clinical Cancer Research ·Lina Odqvist, Margarita Sánchez‐Beato, Santiago Montes‐Moreno, Esperanza Martín‐Sánchez, Raquel Pajares, Lydia Sánchez-Verde, Pablo L. Ortiz‐Romero, José Rodríguez, Socorro Marıá Rodríguez-Pinilla, (unknown), (unknown), (unknown), Teresa Flores, (unknown), (unknown), (unknown), Miguel Á. Piris	44
16	Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas 2012 ·Haematologica ·Esperanza Martín‐Sánchez, Socorro Marıá Rodríguez-Pinilla, Margarita Sánchez‐Beato, Luís Lombardía, (unknown), Diana Romero, (unknown), Pablo García‐Sanz, Magdalena B. Wozniak, Guido Kurz, Carmen Blanco‐Aparicio, Manuela Mollejo, Jorge Lino Alves, Javier Menárguez, (unknown), José Luis Rodríguez‐Peralto, Pablo L. Ortiz‐Romero, Juan F. Garcı́a, James R. Bischoff, Miguel Á. Piris	21
17	PIM Kinases Inhibition, a Rational Strategy in Peripheral T-Cell Lymphomas, 2011 ·Blood ·Esperanza Martín‐Sánchez, Socorro Marıá Rodríguez-Pinilla, Margarita Sánchez‐Beato, (unknown), Magdalena B. Wozniak, Manuela Mollejo, (unknown), José Luis Rodríguez‐Peralto, Javier Menárguez, Juan C. Cigudosa, Pablo L. Ortiz‐Romero, Juan F. Garcı́a, James R. Bischoff, Miguel Á. Piris	0
18	PI3K Inhibition As a Potential Therapeutic Strategy in Peripheral T-Cell Lymphomas, 2011 ·Blood ·Esperanza Martín‐Sánchez, Socorro Marıá Rodríguez-Pinilla, Luís Lombardía, (unknown), Margarita Sánchez‐Beato, Diana Romero, Magdalena B. Wozniak, Manuela Mollejo, Javier Alves, José Luis Rodríguez‐Peralto, Javier Menárguez, Juan C. Cigudosa, Pablo L. Ortiz‐Romero, Juan F. Garcı́a, James R. Bischoff, Miguel Á. Piris	0
19	PI3KCA and PIM Inhibitors in Peripheral T-Cell Lymphomas 2010 ·Blood ·Esperanza Martín‐Sánchez, Socorro Marıá Rodríguez-Pinilla, Luís Lombardía, Margarita Sánchez‐Beato, (unknown), Diana Romero, (unknown), Pierfrancesco Vargiu, (unknown), Manuela Mollejo, (unknown), Magdalena B. Wozniak, James R. Bischoff, Miguel Á. Piris	1
20	Chromosome Instability in Lymphocytes of Children With Coeliac Disease 2009 ·Journal of Pediatric Gastroenterology and Nutrition ·(unknown), Iñaki Irastorza, (unknown), Esperanza Martín‐Sánchez, Idoia Martín‐Guerrero, Javier Ballesteros, Juan Carlos Vitoria, África García‐Orad	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact